INVESTMENT HOLDINGS PRIMARY & SECONDARY MARKETS

Find Value.
Be Time's Friend.

Morroway is an investment holdings company. We deploy capital across primary markets (private equity Β· venture capital Β· buyouts) and secondary markets (public equities Β· fixed income). We invest in creative consumer, wellness, and beauty β€” we back the companies shaping tomorrow's markets.

30+Portfolio Companies
2.5B+Total AUM
25%+Average IRR

Think Long.
Invest Deep.

Morroway Investment Holdings deploys capital where conviction meets opportunity. We invest our own capital and managed funds into exceptional companies across the globe. Our investments span primary markets (private equity, venture capital, control buyouts) and secondary markets (public equities, fixed income, structured products). Our sectors: creative consumer, wellness, and beauty β€” industries we understand deeply and invest in confidently.

🏒

Primary Market Investments

Direct private investments in high-growth companies. From early-stage venture capital to growth equity and control buyouts β€” we identify, acquire, and actively build category-defining brands.

πŸ“ˆ

Secondary Market Investments

Strategic public market positions in leading global companies across trade, consumer, wellness, and beauty. Disciplined value investing in equities, fixed income, and derivatives.

πŸ’Ž

Our Investment Philosophy

We invest with conviction, not speculation. Every position β€” private or public β€” is backed by rigorous fundamental research, deep sector expertise, and a long-term value creation mindset.

🌍

Global Investment Reach

Portfolio exposure across 50+ countries. We invest wherever we find value β€” with on-the-ground intelligence, cross-border expertise, and a truly global investor's perspective.

πŸ“Š

Investment Research & Analysis

Our dedicated research division produces in-depth sector reports, value-oriented equity research, and macro investment theses. Every investment decision is grounded in proprietary analysis β€” combining quantitative models with qualitative industry intelligence.

πŸ”’

Quantitative Investment Solutions

We deploy systematic strategies powered by advanced data analytics, risk modeling, and algorithmic execution. Our quantitative capabilities enhance portfolio construction, optimize risk-adjusted returns, and provide institutional-grade investment services.

Typical Investment Areas

We deploy capital across primary and secondary markets in high-growth consumer sectors β€” each selected for resilient demand, innovation potential, and global scalability.

PRIMARY MARKET

STEM Education Platforms

We invest in innovative educational technology and hands-on learning companies that inspire the next generation of creators and engineers.

PRIMARY MARKET

Creative Arts & Design Brands

Backing premium arts, crafts, and creative expression brands that serve consumers from hobbyists to professional designers worldwide.

SECONDARY MARKET

Interactive Learning Technology

Investing in both private and publicly-listed companies that merge smart technology with early childhood development.

PRIMARY MARKET

Nutraceutical & Supplement Brands

We invest in science-backed nutrition and dietary supplement companies with GMP-certified manufacturing and strong clinical validation.

SECONDARY MARKET

Clean Beauty & Skincare

Strategic investments in leading public and private beauty brands β€” clean ingredients, sustainable sourcing, and scientifically proven formulations.

PRIMARY MARKET

Health & Wellness Tech

Investing in personal health monitoring, therapeutic devices, and digital wellness platforms that redefine consumer healthcare.

PRIMARY MARKET

Innovative Biopharma

We invest in next-generation biopharmaceutical companies developing novel therapies β€” from monoclonal antibodies to cell and gene therapies β€” with strong pipelines and global regulatory pathways.

PRIMARY MARKET

Respiratory & Specialty Pharma

Backing specialized pharmaceutical companies with proven commercial-stage products in respiratory, CNS, and rare disease segments β€” including industry leaders like Baoji Pharma and Changfeng Pharma.

SECONDARY MARKET

Vaccine & Immunotherapy

Strategic positions in publicly-listed vaccine and immunotherapy leaders β€” companies advancing prophylactic and therapeutic solutions for global health challenges.

Proven Performance Across Market Cycles

Our disciplined, cross-market approach has delivered consistent, industry-leading returns. Every number reflects our commitment to rigorous fundamental research and long-term value creation.

25%
Average Annualized IRR

Net IRR across all primary market investments since inception, consistently outperforming industry benchmarks.

2.5B+
Total Assets Under Management

Capital deployed across primary private equity, venture capital, and secondary public market portfolios globally.

15+
Successful Exits & IPOs

Portfolio companies taken public or strategically acquired, generating superior returns for our investors and partners.

3.2x
Average MOIC

Multiple on Invested Capital across realized primary market investments β€” turning vision into measurable value.

Our Investment Approach

We combine deep primary market operational expertise with sophisticated secondary market analysis β€” a dual-lens approach that generates alpha across market cycles.

πŸ”¬

Deep Fundamental Research

Rigorous bottom-up analysis for every investment β€” whether private or public. Industry expertise, management assessment, and financial modeling drive every capital allocation decision.

πŸ”„

Cross-Market Synergy

Insights from private company operations inform public market positioning. Secondary market intelligence reveals primary investment opportunities. Both worlds feed each other.

πŸ›‘οΈ

Risk-Managed Returns

Diversified across primary/ secondary, geography, and sector. Downside protection through structured entry, active monitoring, and disciplined exit timing.

🀝

Aligned Long-Term Partnership

Our principals co-invest alongside LPs. Patient capital with a multi-year horizon β€” because the best returns compound over time, not quarters.

Primary & Secondary Market Strategies

We deploy capital flexibly across the investment spectrum β€” from private company building to public market investing β€” with a unified philosophy of disciplined value creation.

P1

Growth Equity

Minority and majority growth capital in proven consumer brands. We fuel expansion into new markets, channels, and product categories β€” driving top-line acceleration and operational scale.

P2

Buyout & Control Investments

Majority acquisitions of established companies with strong cash flows. We drive transformative value through operational enhancement, management optimization, and strategic repositioning.

P3

Brand Incubation & Venture

Building consumer brands from the ground up. We identify market white spaces, deploy seed-to-Series A capital, and provide hands-on operating support to launch category winners.

S1

Strategic Public Equity

Long-only and long-biased public equity positions in leading global consumer, wellness, and beauty companies. Sector expertise drives superior stock selection and entry/exit timing.

S2

Fixed Income & Credit

Strategic allocation to corporate bonds, convertible notes, and structured credit instruments within the consumer sector β€” generating yield while managing portfolio risk.

S3

Special Situations & Derivatives

Opportunistic investments in spin-offs, merger arbitrage, and event-driven situations. Hedging strategies using options and derivatives to enhance risk-adjusted returns.

Trusted by Founders & Investors

Let's Grow Together

Whether you're a founder seeking investment, an LP exploring fund opportunities, a public company looking for strategic capital, or a partner with a deal to share β€” we'd love to hear from you.

invest@morroway.com
Unit 1508, Tower B, Regent Centre, 63 Wo Yi Hop Road, Kwai Chung, Hong Kong

Thank you! We'll get back to you within 24 hours.